Patent · US Expired

Polypeptide compositions and methods

US4190646A · kind A · utility

20Cited by
4References
32Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 26, 1979
Grant dateFeb 26, 1980
Priority date
Expiry dateJan 26, 1999

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S930/18
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There are disclosed polypeptide compositions having the following amino acid sequence as the active site: EQU ARG-LYS-ASP-VAL-TYR These polypeptides have the capability of inducing the differentiation of T-lymphocytes but not of complement receptor (CR.sup.+) B-lymphocytes and thus are useful in a number of therapeutic areas. Also provided are derivatives of the pentapeptide, novel intermediate polypeptides, methods of manufacture of the peptides, therapeutic compositions, and methods for use of the compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.